Company Affair

Annapolis - Bio-defense research company PharmAthene Inc., announced last week it had been selected for a $13.9 million federal contract to develop therapies against bacterial diseases.

Read More at The Capital…

This entry was posted on Sunday, September 30th, 2007 at 12:28 pm and is filed under Company News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.